These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6235883)

  • 1. Nutritional aspects of Down's syndrome with special reference to the nervous system.
    Sylvester PE
    Br J Psychiatry; 1984 Aug; 145():115-20. PubMed ID: 6235883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair trace metal levels in Down syndrome patients.
    Barlow PJ; Sylvester PE; Dickerson JW
    J Ment Defic Res; 1981 Sep; 25(Pt 3):161-8. PubMed ID: 6456356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome: nutritional intervention.
    Reading CM
    Nutr Health; 1984; 3(1-2):91-111. PubMed ID: 6242480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioelements in hair of children with selected neurological disorders.
    Józefczuk J; Kasprzycka W; Czarnecki R; Graczyk A; Józefczuk P; Krzysztof M; Lampart U; Mrozowska-Ząbek E; Surdy W; Kwiatkowska-Graczyk R
    Acta Biochim Pol; 2017; 64(2):279-285. PubMed ID: 28612063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair Mineral and Trace Element Content in Children with Down's Syndrome.
    Grabeklis AR; Skalny AV; Skalnaya AA; Zhegalova IV; Notova SV; Mazaletskaya AL; Skalnaya MG; Tinkov AA
    Biol Trace Elem Res; 2019 Mar; 188(1):230-238. PubMed ID: 30209729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in soluble brain proteins in older subjects with Down's syndrome.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 May; 68(2-3):205-14. PubMed ID: 3159852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and Down's syndrome.
    Price DL; Whitehouse PJ; Struble RG; Coyle JT; Clark AW; Delong MR; Cork LC; Hedreen JC
    Ann N Y Acad Sci; 1982; 396():145-64. PubMed ID: 6217772
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of vitamins and trace minerals.
    Kennedy-Caldwell C; Hanson ME
    Nurs Clin North Am; 1983 Mar; 18(1):29-45. PubMed ID: 6550866
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.